Opus Genetics, Inc.: operating cash flow
Operating cash flow for Opus Genetics, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Opus Genetics, Inc. financial histories
What this measure means
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
Exact concept: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2017-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -35,253,000 | USD | 2026-03-12 | 10-K · 0001140361-26-009247 |
| 2024-01-01 | 2024-12-31 | -25,576,000 | USD | 2026-03-12 | 10-K · 0001140361-26-009247 |
| 2023-01-01 | 2023-12-31 | -1,112,000 | USD | 2025-03-31 | 10-K · 0001140361-25-011410 |
| 2022-01-01 | 2022-12-31 | 14,314,000 | USD | 2024-03-08 | 10-K · 0001140361-24-012399 |
| 2021-01-01 | 2021-12-31 | -19,370,000 | USD | 2023-03-30 | 10-K · 0001140361-23-014868 |
| 2020-01-01 | 2020-12-31 | -6,797,000 | USD | 2022-03-24 | 10-K · 0001140361-22-011015 |
| 2019-01-01 | 2019-12-31 | -3,593,000 | USD | 2021-03-11 | 10-K · 0001140361-21-008099 |
| 2018-01-01 | 2018-12-31 | -18,838,638 | USD | 2020-02-21 | 10-K · 0001140361-20-003785 |
| 2017-01-01 | 2017-12-31 | -15,420,055 | USD | 2019-03-07 | 10-K · 0001140361-19-004539 |
Related financial histories
- Opus Genetics, Inc.: total assets
- Opus Genetics, Inc.: total liabilities
- Opus Genetics, Inc.: stockholders equity
- Opus Genetics, Inc.: cash and cash equivalents
- Opus Genetics, Inc.: net income or loss
- Opus Genetics, Inc.: revenue
- Opus Genetics, Inc.: contract revenue excluding tax
- Opus Genetics, Inc.: financing cash flow
- Opus Genetics, Inc.: investing cash flow
- Opus Genetics, Inc.: retained earnings or deficit
- Opus Genetics, Inc.: basic weighted-average shares
- Opus Genetics, Inc.: diluted weighted-average shares
- Opus Genetics, Inc.: basic earnings per share
- Opus Genetics, Inc.: diluted earnings per share
- Opus Genetics, Inc.: income tax expense or benefit
- Opus Genetics, Inc.: net property, plant and equipment
- Opus Genetics, Inc.: share-based compensation expense
- Opus Genetics, Inc.: operating income or loss
- Opus Genetics, Inc.: current assets
- Opus Genetics, Inc.: interest expense
- Opus Genetics, Inc.: current liabilities
- Opus Genetics, Inc.: current accounts payable
- Opus Genetics, Inc.: net current accounts receivable
- Opus Genetics, Inc.: operating expenses
- Opus Genetics, Inc.: research and development expense
Inspect the source
- Entity
- Opus Genetics, Inc. / CIK 0001228627
- Captured
- 2026-09-20T07:46:24.028Z
- SEC response SHA-256
59b3f548361fa5c66fb8bd927bac9bc7dc8822bcce158860c7c4d77974af0a92
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001228627.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))